Thursday, May 5, 2016

RPT-UPDATE 2-Merck sales disappoint as Januvia, Remicade fall short

May 5 (Reuters) - Merck & Co Inc on Thursday

reported lower-than-expected quarterly revenue, hurt by

disappointing sales of its Januvia diabetes treatment and

Remicade arthritis drug.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)